Angiotensin-converting enzyme 2 connects COVID-19 with cancer and cancer immunotherapy

doi:10.4251/wjgo.v13.i3.157

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5008)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

235

WORD

180

HTML

2335

Figures (1-1)

260

Sum=3010

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

363

Download

561

Sum=924

Publishing Process of This Article

Item

Count

Browse

405

Download

669

Sum=1074

Mar 15, 2021 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastrointest Oncol. Mar 15, 2021; 13(3): 157-160
Published online Mar 15, 2021. doi: 10.4251/wjgo.v13.i3.157

Open in New Tab Full Size Figure Download Figure

Figure 1 An illustration of the relationships between angiotensin-converting enzyme 2, coronavirus disease 2019, and cancer. ACE2: Angiotensin-converting enzyme 2; COVID-19: Coronavirus disease 2019; EMT: Epithelial-mesenchymal transition; PD-L1: Programmed death-ligand 1; TGF-β: Transforming growth factor-β; VEGF: Vascular endothelial growth factor.

Citation: Wang XS. Angiotensin-converting enzyme 2 connects COVID-19 with cancer and cancer immunotherapy. World J Gastrointest Oncol 2021; 13(3): 157-160
URL: https://www.wjgnet.com/1948-5204/full/v13/i3/157.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i3.157